[144] Innovative Eyewear, Inc. Series A Warrants 8/16/27 SEC Filing

Rhea-AI Filing Summary

Innovative Eyewear, Inc. (ticker: LUCYW) Form 144 notice reports a proposed sale of 2,596 common shares valued at an aggregate $5,057.55 to be sold through Raymond James & Associates on 08/19/2025 on NASDAQ. The filer shows the shares were acquired the same day, 08/19/2025, as an RSU grant from the issuer representing 8,400 shares granted, with the reported form indicating cash payment. The filing lists total shares outstanding as 4,574,602. No securities were reported sold by the filer in the prior three months and no additional remarks or plan-adoption dates are provided.

Insights

Securities Analyst

TL;DR: Routine Rule 144 sale of recently vested RSUs; small position relative to outstanding shares, limited immediate market impact.

The filing documents a proposed sale under Rule 144 of 2,596 common shares derived from an RSU grant of 8,400 shares vesting/acquired on the trade date, with an aggregate market value of $5,057.55. The transaction is to be executed via Raymond James on NASDAQ on 08/19/2025. Given the issuer's 4,574,602 shares outstanding, the sale represents a de minimis percentage of the float. The notice includes no prior sales in the past three months and does not state any 10b5-1 plan adoption date.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; no governance red flags present in the form as filed.

The Form 144 provides the required seller and transaction details: class, broker, quantity, aggregate value, acquisition date and nature (RSU grant), and payment method (cash). The signer attests to absence of undisclosed material adverse information, and the filing shows no aggregated sales in the prior three months. The document does not include any additional governance disclosures, restrictions, or indications of trading-plan timing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	2596	5057.55	4574602	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	RSU Grant	Issuer			8400	08/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for LUCYW report for sale?

The notice reports a proposed sale of 2,596 common shares of Innovative Eyewear, Inc.

When will the LUCYW shares be sold and on which exchange?

The sale is scheduled for 08/19/2025 to be executed on NASDAQ through Raymond James & Associates.

How were the shares being sold acquired according to the filing?

The shares were acquired on 08/19/2025 as an RSU grant from the issuer; the filing shows 8,400 shares granted and cash payment noted.

What is the aggregate market value and how many shares are outstanding?

Aggregate market value is reported as $5,057.55 and total shares outstanding are listed as 4,574,602.

Were any securities sold by the filer in the prior three months?

The filing states Nothing to Report for securities sold during the past three months.